Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Anthony Azzi

Internal Medicine Raleigh, NC Medical Doctor

NPI 1447228283 CMS profile 1201193

3000 New Bern Ave, Raleigh, NC 27610

Open in the dashboard

General payments

$81,371

296 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Anthony Azzi of Raleigh, NC is reported in the CMS Open Payments database as having received $81,371 across 296 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $128 3
2022 General $3,544 12
2021 General $902 12
2020 General $33,276 86
2019 General $43,520 183

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Azzi
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Anthony Azzi were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Anthony Azzi Internal Medicine median Middle half National median
2019 $43,520 $159 $48–$570 $163
2020 $33,276 $119 $33–$402 $114
2021 $902 $135 $37–$521 $132
2022 $3,544 $141 $42–$496 $149
2023 $128 $149 $45–$519 $160
2024 $0 $154 $47–$537 $164
2025 $0 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AstraZeneca Pharmaceuticals LP $52,016 76 payments
  2. Mannkind Corporation $22,104 67 payments
  3. Insulet Corporation $5,226 17 payments
  4. Novo Nordisk Inc $270 21 payments
  5. Medtronic MiniMed, Inc. $264 17 payments
  6. Amgen Inc. $201 16 payments
  7. Amarin Pharma Inc. $167 9 payments
  8. Zealand Pharma US, Inc. $164 2 payments
  9. Janssen Pharmaceuticals, Inc $113 19 payments
  10. Sanofi-Aventis U.S. LLC $97 7 payments
  11. Other $751 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $65,425 34 payments
  2. Consulting Fee $6,183 2 payments
  3. Food and Beverage $4,899 224 payments
  4. Travel and Lodging $4,735 32 payments
  5. Education $70 3 payments
  6. Gift $59 1 payment
Products named General payments · program years 2019–2023
  1. FARXIGA $51,875 74 payments
  2. AFREZZA Diabetes Medicine $12,630 33 payments
  3. AFREZZA Diabetes Medicine $9,474 34 payments
  4. Omnipod $5,226 17 payments
  5. Minimed 670G System $264 17 payments
  6. V-GO DISPOSABLE INSULIN DELIVERY $164 2 payments
  7. Vascepa $155 8 payments
  8. Ozempic $144 12 payments
  9. Prolia $143 10 payments
  10. LOKELMA $141 2 payments
  11. Other $1,758 130 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$29,289

Medicare's payments for the services billed

Medicare patients

264

Average age 76

Services billed

294

152 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Diabetes 49%
Chronic kidney disease 45%
Ischemic heart disease 44%
Heart failure 40%
Depression 38%
Atrial fibrillation 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

296 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record